series-b
Stage
1
Investors
About
Sêmeia specializes in telemonitoring and digital health, offering MedicWise, an intuitive solution for real-time patient monitoring by healthcare teams, particularly focusing on chronic disease management in nephrology with its leading product NephroWise.
Explore Sêmeia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.